Science & Enterprise subscription

Follow us on Twitter

  • New contributed post on Science and Enterprise: Ships Are Becoming Safer With Technology
    about 2 hours ago
  • A panel of data and behavioral scientists envision great potential for blockchain in science, but show few cases o…
    about 22 hours ago
  • New post on Science and Enterprise: Blockchain and Science, Not Ready for Prime Time #Science #Business #AAASmtg
    about 22 hours ago
  • New contributed post on Science and Enterprise: Slips And Falls, Underestimated Workplace Hazards
    about 23 hours ago
  • An experimental drug is shown in a clinical trial and computer modeling to reduce the mass of smooth muscle tissue…
    about 2 days ago

Please share Science & Enterprise

Follow by Email
Visit Us

In Case You Missed It …

(tigerlily713, Pixabay)

29 July 2018. Among our favorite stories on Science & Enterprise are when interesting science becomes a business opportunity. Last Wednesday, we reported on Convelo Therapeutics, a spin-off enterprise from Case Western Reserve University in Cleveland, commercializing research by its two geneticist founders that stimulate stem cells to replenish damaged myelin around nerve cells in the brain. Myelin is the waxy substance protecting nerve cells that gets destroyed by multiple sclerosis. The company emerged from stealth mode when the founders published papers in two Nature journals on Wednesday.

Here are other stories we covered last week:

*     *     *

Please share Science & Enterprise ...

Comments are closed.